NEW FRONTIERS IN PATHOLOGY Case 1 Gynecological Pathology - PowerPoint PPT Presentation

1 / 38
About This Presentation
Title:

NEW FRONTIERS IN PATHOLOGY Case 1 Gynecological Pathology

Description:

NEW FRONTIERS IN PATHOLOGY Case 1 Gynecological Pathology – PowerPoint PPT presentation

Number of Views:139
Avg rating:3.0/5.0
Slides: 39
Provided by: university57
Category:

less

Transcript and Presenter's Notes

Title: NEW FRONTIERS IN PATHOLOGY Case 1 Gynecological Pathology


1
NEW FRONTIERS IN PATHOLOGYCase 1Gynecological
Pathology
  • Kathleen R. Cho, M.D.

kathcho_at_umich.edu
2
History
  • 20 yo G4P1 woman was referred for management of
    two abnormal pap smears a few months after normal
    vaginal delivery at term
  • Colposcopy showed aceto-white staining of entire
    transformation zone, abnormal vascular pattern
  • Testing for high-risk HPV types negative
  • Cervical biopsies were obtained

3
(No Transcript)
4
(No Transcript)
5
(No Transcript)
6
(No Transcript)
7
AE1/AE3/CAM5.2
8
p63
9
p16
10
hCG
11
hPL
12
Inhibin
13
Ki67
14
Dx Epithelioid Trophoblastic Tumor
Additional History
  • Cone biopsy was performed and showed residual ETT
    extending to endocervical margin
  • ETT also present in concurrent endocervical
    curettings
  • No residual tumor identified in subsequent
    hysterectomy
  • Patient lost to follow-up (no news is good news?)

15
(No Transcript)
16
(No Transcript)
17
Epithelioid Trophoblastic Tumor
  • Term first introduced by Mazur and Kurman
    (Blausteins Pathology of the Female Genital
    Tract, 4th ed, 1994)
  • First series (n14) reported by Shih and Kurman,
    1998
  • ETT now widely accepted as distinct diagnostic
    entity within the spectrum of gestational
    trophoblastic tumors

18
Clinical Features
  • Patients usually premenopausal (mean age 38),
    rarely postmenopausal
  • Usually present with abnormal vaginal bleeding
  • Serum hCG is elevated (broad range, usually not
    markedly elevated)
  • Associated with previous pregnancy, often remote
    (mean 76 mos.)
  • Associated with previous molar pregnancy (36)
  • 13 of patients reported dead from disease, but
    overall survival/recurrence statistics unclear
    (rare tumor, poor follow-up)

19
Pathologic Features - Gross
  • Discrete solid and cystic masses in uterine
    fundus, lower uterine segment, or endocervix
    (approx. half in LUS or Cx)
  • Variable amounts of hemorrhage and necrosis
  • May present in extra-uterine locations without
    demonstrable uterine disease (small bowel, lung)

20
Pathologic Features - Microscopic
  • Generally circumscribed but foci of infiltrating
    cells often present at tumor periphery
  • Relatively uniform population of trophoblastic
    cells with single nucleus
  • Geographic necrosis often present
  • Cells usually arranged in nests, cords and masses
    associated with eosinophilic, sometimes
    fibrillar, hyaline-like material (simulates
    keratin)

21
(No Transcript)
22
Pathologic Features - Microscopic
  • When cervix is involved, the tumor cells have a
    propensity to replace surface and endocervical
    glandular epithelium, simulating SIL
  • Check clinical history for HPV-related lesions,
    HPV status, etc.
  • May be mixed with areas resembling PSTT or
    choriocarcinoma
  • Foci resembling placental site nodule (PSN) often
    present (PSN as possible precursor ??)

23
(No Transcript)
24
Schematic representation of the trophoblastic
subpopulations in the placenta and fetal
membranes
IeM Shih and RJ Kurman, Int J Gynecol Pathol
2001 2031-47
25
LESIONS OF INTERMEDIATE TROPHOBLAST
Exaggerated placental site (EPS) Placental site
trophoblastic tumor (PSTT)
IMPLANTATION SITE intermediate trophoblast
Villous intermediate trophoblast
CHORIONIC-TYPE intermediate trophoblast
Placental site nodule (PSN) Epithelioid
trophoblastic tumor (ETT)
26
Immunostaining Algorithm for Trophoblastic Lesions
Modified from Shih and Kurman, Am J Surg Pathol,
281177-83, 2004
3
27
n15 ITTs (8 PSTTs, 4 ETTs, 3 mixed
(ETT/PSTT/Choriocarcinoma) n11 Choriocarcinomas
(pure) n10 Cervical carcinomas (5 pure squamous
and 5 adenosquamous)
Note p16 positivity in cervical carcinomas is
strong, diffuse, and includes nuclear staining,
while staining in ITTs, when present, is usually
focal and cytoplasmic
Modified from Table 2, Immunohistochemical
Studies of Trophoblastic Tumors, N. Kalhor et
al., Am J Surg Pathol, 33633-638, 2009.
28
Molecular Genetics of ETT
  • Two studies have confirmed the trophoblastic
    (fetal) nature of ETTs
  • Y chromosome markers
  • Novel paternal alleles
  • Analysis of small number of cases by comparative
    genomic hybridization failed to identify
    consistent chromosomal losses or gains

29
ETT vs. PSTT
  • PSTTs usually more infiltrative (less
    circumscribed)
  • PSTT cells usually larger, more pleomorphic
  • PSTT growth pattern is more sheet-like, rather
    than nests or cords
  • PSTT displays characteristic invasion of vessel
    walls

30
(No Transcript)
31
(No Transcript)
32
(No Transcript)
33
ETT vs. Choriocarcinoma
  • ETTs lack the dimorphic population of trophoblast
    seen in choriocarcinomas
  • Choriocarcinomas usually more hemorrhagic

34
(No Transcript)
35
(No Transcript)
36
ETT vs. Placental Site Nodule
  • PSNs usually microscopic (vs. ETT mass lesion)
  • PSNs less cellular than ETTs
  • PSNs more diffusely hyalinized
  • PSNs not mitotically active
  • Atypical PSNs ?

37
(No Transcript)
38
SUMMARY
  • ETT is a neoplasm of chorionic-type intermediate
    trophoblast
  • Most cases behave in a benign fashion, but some
    do not
  • Criteria allowing prediction of malignant
    behavior remain uncertain (? increased mitotic
    activity)
  • ETT can closely mimic cervical squamous cell
    carcinomas
  • Dx usually straightforward if given consideration!
Write a Comment
User Comments (0)
About PowerShow.com